Critical Appraisal Tools for Veterinary Research: A Comparative Review

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Critical appraisal tools operationalize the assessment of internal validity, external validity, and reporting completeness in veterinary studies, converting implicit judgments into structured checklists to systematically compare and weight evidence.
• The Cochrane Risk of Bias tool is recommended for randomized controlled trials, the Newcastle-Ottawa Scale for cohort and case-control studies, and MINORS for non-randomized interventional studies, with each tool designed to address specific threats to validity inherent in their respective designs.
• A significant limitation is that most appraisal tools were developed for human clinical trials and do not adequately address veterinary-specific biases such as client consent bias, breed/species differences in outcome validity, or unit-of-analysis errors in group-housed animals.
• The psychometric properties of critical appraisal tools, including inter-rater reliability and validation status, are poorly characterized, with many tools lacking rigorous testing, necessitating careful documentation of appraisal processes and inter-rater reliability statistics.
• Reporting standards like ARRIVE 2.0 and REFLECT are crucial complements to appraisal tools, ensuring that studies report sufficient methodological detail to allow for a thorough assessment of bias and to distinguish between reporting failures and actual methodological flaws.
• Veterinary researchers must supplement generic appraisal tools with specific checks for veterinary-specific threats to validity, such as allocation bias from client consent, breed/species comparability, and appropriate unit-of-analysis considerations, to ensure a comprehensive assessment.

Veterinary researchers increasingly rely on systematic reviews, meta-analyzes, and structured evidence syntheses to inform clinical decisions, yet the quality of these syntheses depends on the rigor of the critical appraisal tools applied to the primary studies. This article compares the major critical appraisal tools available to veterinary researchers, examines their design origins, and assesses their suitability for cross-species clinical and preclinical research. It serves researchers who must select an appraisal instrument for a review protocol, interpret the results of published syntheses, or justify their methodological choices to funders and journal editors.

The central question addressed here is practical: which tool should a veterinary researcher apply to a given study design, and what are the consequences of that choice? Evidence from the human health literature indicates that the selection of an appraisal tool does not necessarily alter the direction of an evidence synthesis, but it does affect inter-rater reliability and the components of study quality that receive scrutiny. Understanding these differences matters for veterinary research, where study designs often deviate from the human clinical templates that most tools were built to assess.

At a Glance

The Conceptual Basis of Critical Appraisal

Critical appraisal tools operationalize the assessment of internal validity, external validity, and reporting completeness in individual studies. They convert implicit judgments about methodological quality into structured checklists or rating scales, allowing reviewers to compare studies systematically and to weight evidence in a synthesis. The underlying logic is that certain design features, such as randomization, allocation concealment, blinding, and complete outcome reporting, protect against systematic error, and that the presence or absence of these features can be assessed reliably by trained reviewers.

The development of appraisal tools has not followed a uniform scientific standard. A review of 44 published critical appraisal tools found that only 11% provided comprehensive explanations of their development process and usage guidelines, while 25% reported no validation process and 77% had not been reliability tested. This means that many tools in active use have unknown measurement properties, and their results should be interpreted with corresponding caution.

Major Tool Families and Their Origins

Critical Appraisal Skills Program

The Critical Appraisal Skills Program (CASP) produces checklists for randomized controlled trials, cohort studies, case-control studies, diagnostic test accuracy studies, qualitative research, and systematic reviews. CASP tools are widely used because they are freely available, brief, and structured around three domains: validity of results, magnitude and precision of effect, and applicability to local settings. In the systematic review of methodological assessment tools, CASP was identified as the second most prolific developer of appraisal instruments, after the Joanna Briggs Institute.

CASP checklists use a three-point response format (yes, no, cannot tell) followed by prompts for reviewer judgment. This design supports rapid screening but produces categorical data that may not discriminate finely between studies of intermediate quality. For veterinary reviews that include heterogeneous study designs, CASP tools offer a practical starting point, but their brevity can obscure subtle methodological differences.

Joanna Briggs Institute

The Joanna Briggs Institute (JBI) has developed the largest family of critical appraisal tools, covering experimental, quasi-experimental, observational, qualitative, economic, and text-based evidence. JBI tools are notable for their design-specific granularity, with separate instruments for cohort studies, case-control studies, analytical cross-sectional studies, case series, case reports, and prevalence studies. This breadth makes JBI tools attractive for veterinary systematic reviews, which frequently include observational and descriptive study types that other instruments do not accommodate.

JBI tools use four-point response scales (yes, no, unclear, not applicable) and include guidance documents for each instrument. Their application in published systematic reviews is well documented, including use in reviews of complex health system interventions and in assessments of endothelial dysfunction and frailty. The JBI approach emphasizes the assessment of methodological quality as a component of a broader evidence synthesis workflow that includes study selection, data extraction, and certainty assessment.

Cochrane Risk of Bias Tools

The Cochrane Collaboration's risk of bias tool for randomized controlled trials was judged the best available instrument for this design in the systematic review of assessment tools. The original tool assessed sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other sources of bias. The revised version, RoB 2.0, organizes judgments by randomization process, deviations from intended interventions, missing outcome data, measurement of the outcome, and selection of reported results.

Cochrane tools are domain-based instead of checklist-based, requiring reviewers to make a judgment about risk of bias for each domain and to support that judgment with a rationale. This structure produces more informative assessments than simple summary scores, but it demands reviewer training and familiarity with the underlying bias concepts. Veterinary randomized trials that follow reporting standards such as ARRIVE 2.0 and REFLECT can be assessed with these tools, though the tools do not account for species-specific design features such as allocation of group-housed animals or blinding of outcome assessors in field settings.

Newcastle-Ottawa Scale and MINORS

The Newcastle-Ottawa Scale (NOS) was developed for assessing the quality of non-randomized studies in meta-analyzes, with separate versions for cohort and case-control designs. It uses a star-based rating system across selection, comparability, and outcome or exposure domains. The systematic review of assessment tools recommends NOS for cohort and case-control studies, and it remains one of the most frequently used instruments in veterinary systematic reviews of observational research.

The Methodological Index for Non-Randomized Studies (MINORS) was designed for non-randomized interventional studies, including both comparative and non-comparative designs. It includes 12 items for comparative studies and 8 for non-comparative studies, covering clearly stated aims, inclusion of consecutive patients, prospective data collection, unbiased outcome assessment, and adequate follow-up. MINORS is particularly relevant to veterinary surgery and internal medicine research, where randomized allocation is often impractical and prospective cohort designs predominate.

The Problem of Tool Validation

The psychometric properties of critical appraisal tools, including inter-rater reliability, test-retest reliability, and construct validity, are poorly characterized across the field. In one study comparing four appraisal tools applied to 32 systematic reviews, inter-rater reliability varied substantially, with Cohen's kappa ranging from 0.47 to 0.76, and the heterogeneity between reviewer pairs was high. Notably, the choice of tool did not change the overall result of the evidence synthesis, suggesting that while tools differ in their components and reliability, they may converge on similar conclusions about overall study quality.

For veterinary researchers, this has two practical implications. First, the selection of a tool should be driven by the study designs included in the review and by the reporting standards those studies are expected to meet, instead of by assumptions about one tool being inherently superior. Second, reviews that use appraisal tools should report inter-rater reliability statistics and resolve disagreements through consensus or a third reviewer, because the reliability of the appraisal process is a property of the reviewers as much as the instrument.

Reporting Standards as a Complement to Appraisal

Critical appraisal tools assess what was done in a study, but they cannot assess what was done but not reported. Reporting standards address this gap by specifying the minimum information that should appear in a publication. The ARRIVE guidelines 2.0 define the essential items for transparent and reproducible animal research, including sample size calculation, randomization, blinding, and exclusion criteria. The EQUATOR Network maintains a comprehensive library of reporting guidelines, including CONSORT for randomized trials, PRISMA for systematic reviews, STROBE for observational studies, and REFLECT for livestock and food safety trials.

Veterinary researchers should use reporting standards in two ways. When designing a study, adherence to the relevant reporting guideline improves the likelihood that the study will be appraisable by future reviewers. When conducting a systematic review, reporting standards can inform the appraisal tool selection, because a tool that aligns with the reporting items used by the included studies will produce more complete assessments. A study that follows ARRIVE 2.0, for example, will contain the information needed to judge most items on a JBI or Cochrane tool, whereas a study that does not follow such standards may receive low scores that reflect reporting failure instead of methodological failure.

Selecting a Tool for a Given Study Type

The first decision point is matching the tool to the study design. Using a tool designed for randomized trials to appraise a cohort study will produce misleading results, because the items address randomization, allocation concealment, and blinding that the cohort design cannot satisfy. Conversely, applying a cohort tool to a trial ignores the very features that protect the trial from bias.

For randomized controlled trials, the Cochrane Risk of Bias tool remains the most defensible choice. A systematic review of methodological assessment tools concluded that the Cochrane tool was the best available for assessing RCTs, a judgment based on its coverage of bias domains instead of a simple checklist of reporting items. The tool forces the appraiser to judge the risk of bias within each domain, also to record whether a detail was reported.

For cohort and case-control studies, the Newcastle-Ottawa Scale is the most frequently recommended instrument. The same systematic review identified it as the preferred tool for these designs. Its three broad domains, selection, comparability, and outcome or exposure ascertainment, map cleanly onto the major threats to validity in observational veterinary studies. The comparability domain is particularly relevant in veterinary medicine, where breed, age, and management system frequently confound the exposure-outcome relationship.

For non-randomized interventional studies, the Methodological Index for Non-Randomized Studies (MINORS) is the strongest option. It was developed specifically for surgical and other non-randomized interventions and includes items that generic checklists omit, such as unbiased assessment of the study endpoint and adequate follow-up. Veterinary surgical studies, many of which cannot be randomized for ethical or practical reasons, are a natural fit for this instrument.

The Veterinary-Specific Gap

None of the major tools was designed with veterinary medicine in mind. The consequence is that several sources of bias common in veterinary research receive little or no attention. The appraisal sequence must therefore include a supplementary assessment of veterinary-specific threats that the generic tool will not capture.

The most important of these is allocation bias arising from client consent. In veterinary trials, owners must consent to randomization, and the proportion of owners who decline can be substantial. If the tool does not ask how consent was obtained and whether decliners differed from participants, the appraiser must add this question manually. A related problem is the use of convenience samples drawn from a single referral hospital, which limits external validity in ways that a generic tool may not flag.

Another gap is the handling of breed and species differences. A tool that asks whether groups were comparable at baseline may not prompt the appraiser to consider whether breed distribution was balanced, whether the study included multiple species, or whether the outcome measure is valid across the breeds enrolled. The appraiser should record these considerations separately.

A third gap concerns the unit of analysis. Veterinary studies frequently house animals in groups, treat them individually, or measure outcomes at the level of the herd or pen. If the analysis unit does not match the intervention unit, the study is at risk of a unit-of-analysis error that inflates precision. No major critical appraisal tool addresses this directly. The appraiser must check the methods and record the unit of analysis explicitly.

A Comparison Table for Common Tools

The table below summarizes the practical characteriztics of the three tool families most likely to be used in veterinary appraisal. The judgments reflect the published evidence on tool development and validation, as well as the documented variability in inter-rater reliability between tools.

The choice between these families is not neutral. A study that compared four appraisal tools applied to the same set of systematic reviews found that inter-rater reliability differed substantially between tools, with Cohen's kappa ranging from 0.47 to 0.76. The same study found that the choice of tool did not change the overall direction of the evidence synthesis, but the reliability differences mean that the tool choice affects the consistency of individual appraisals. For a veterinary research group, this argues for selecting one tool family and using it consistently across all appraisals, instead of mixing tools within a single review.

Practical Appraisal Sequence

A structured sequence reduces the risk of missing a key bias domain. The following protocol is suitable for a single appraiser or a pair working independently.

First, confirm the study design from the methods section, not from the abstract. The abstract may describe a study as a trial when the methods reveal a non-randomized comparison. Record the design and select the corresponding tool.

Second, apply the tool independently. If two appraisers are available, each should complete the tool without consulting the other. The published reliability data show that reviewer pairs can differ substantially even when using the same tool, so independent scoring followed by consensus discussion is the minimum acceptable standard.

Third, add the veterinary-specific checks. Record the species, breeds, and production system. Verify the unit of analysis. Check whether client consent or referral patterns could have introduced selection bias. Note whether the outcome measures are validated for the species studied.

Fourth, document the appraisal. Record the tool used, the date, the appraiser names, and the score or judgment for each item. Where the tool uses a summary score, report it. Where it does not, report the pattern of responses across domains. This documentation allows a future reader to understand why a study was judged to be at high or low risk of bias.

When the Correct Choice Changes

The correct tool depends on the research question, the study design, and the purpose of the appraisal. For a rapid journal club discussion of a single clinical trial, CASP is sufficient and efficient. For a systematic review that will inform clinical recommendations, the JBI tools or the Cochrane Risk of Bias tool are more defensible because they provide structured judgments instead of binary responses. For an overview of systematic reviews, the appraiser should consider whether the tool's psychometric properties have been tested, since the evidence base for tool reliability is thin.

Production system matters. A tool that asks about blinding of outcome assessors is straightforward to apply in a controlled trial of companion animals, but difficult in a field trial of production animals where the outcome is measured by farm staff. The appraiser should record how blinding was handled in the field setting and judge the risk of bias accordingly, instead of forcing the study into a template that does not fit.

Patient status also changes the appraisal. A study of critically ill animals may have high mortality before the outcome is measured, and the tool should prompt the appraiser to consider whether attrition bias was addressed. A study of healthy animals may have ceiling effects that obscure treatment differences. These considerations are not captured by any generic tool and must be added by the appraiser.

Finally, the purpose of the appraisal changes the standard of evidence required. A clinical guideline development group may require a higher standard of evidence than a practice-based research network conducting a preliminary scoping review. The appraisal should be calibrated to the decision that the evidence will inform, and this calibration should be documented in the appraisal record.

Recognized Complications and Failure Modes

Critical appraisal tools fail in predictable ways, and the failure is often silent. The most common complication is construct drift, where a tool designed for one purpose is applied to another without adjustment. A checklist built for randomised trials, when applied to a cohort study, will penalise the study for features that are not design flaws. The discriminating check is to read the tool's stated scope and compare it with the study design before scoring begins.

A second failure mode is score aggregation. Many tools produce a numerical total, and reviewers habitually treat that total as a continuous measure of quality. The problem is that two studies with identical scores can fail on entirely different domains. A study with perfect blinding but poor follow-up is not equivalent to one with poor blinding and complete follow-up. The corrective action is to report domain-level results and to treat the total score as a screening device, not a verdict.

Inter-rater disagreement is the third recognized complication. The available evidence shows that agreement between reviewers varies substantially depending on the tool selected, with reported Cohen's kappa values ranging from 0.47 to 0.76 across four tools applied to the same set of systematic reviews. The source of disagreement is usually ambiguous item wording instead of genuine differences in judgment. Early detection requires a calibration exercise: two reviewers appraise the same three studies independently, compare their responses item by item, and reconcile wording interpretations before the full appraisal set begins.

A fourth failure mode is the checklist illusion. A completed tool gives the impression that quality has been measured, when in fact the tool has only recorded the presence or absence of reported features. Poor reporting can masquerade as poor methodology, and a well-conducted study with incomplete reporting will score poorly. The discriminating check is to distinguish between what the authors did and what they reported, and to consult reporting standards such as the ARRIVE guidelines for animal research when the distinction matters.

Common Errors and Corrective Actions

Less experienced reviewers tend to score items as present or absent without considering partial compliance. A study that reports blinding of outcome assessors but not of caregivers receives a negative score on a dichotomous item, even though the risk of bias is partially mitigated. The corrective action is to use tools that offer partial credit or to record a narrative justification for each item instead of a binary mark.

A second common error is the conflation of appraisal with reporting quality. A study that follows CONSORT or STROBE meticulously is not automatically methodologically sound. The two constructs overlap but are not identical, and the distinction is central to the design of appraisal tools. The corrective action is to appraise the study as conducted, using the report as evidence, not as the object of evaluation itself.

A third error is the application of a single tool across heterogeneous study designs within one review. A systematic review that includes randomised trials, cohort studies, and qualitative work requires a separate tool for each design family. The corrective action is to pre-specify the tool for each design in the review protocol, before the included studies are known.

Limitations of the Current Evidence

The evidence base for the tools themselves is thin. A review of 44 critical appraisal tools found that only 11 percent had comprehensive documentation of their development and usage guidance, 25 percent reported no validation process, and 77 percent had not been reliability tested. This means that most tools in current use have unknown measurement properties, and the choice between them rests on tradition instead of demonstrated superiority.

Expert opinion still differs on whether the choice of tool materially affects the conclusions of a synthesis. One study found that the result of an evidence synthesis was not dependent on the choice of appraisal tool, despite differences in the components covered by each tool. That finding comes from a single context, overviews of hospital volume-outcome relationships, and cannot be generalized to veterinary medicine without caution. The more defensible position is that tool choice matters less than the consistency and transparency of its application.

The veterinary-specific evidence is even more limited. No tool has been developed and validated specifically for veterinary study designs, and the cross-species applicability of human-derived tools remains an assumption. The ARRIVE guidelines address reporting, not appraisal, and the gap between the two is where veterinary reviewers must exercise judgment.

Referral, Consultation, and Escalation

Most appraisal tasks can be completed by a single reviewer with methodological training. Escalation is warranted when the study under appraisal uses an unfamiliar design, when the tool produces borderline or contradictory domain scores, or when the appraisal will inform a decision with regulatory or clinical consequences.

A veterinary librarian or epidemiologist should be consulted when the search strategy and study selection require verification, particularly for reviews that will inform practice guidelines. Laboratory involvement is rarely needed for appraisal itself, but a clinical pathologist or specialist may be required to judge the validity of diagnostic methods or outcome measures in species where reference standards are poorly defined.

Regulatory reporting is not part of the appraisal workflow, but appraisal findings can trigger it. A study that reveals serious adverse events, off-label use with undocumented safety, or welfare concerns may warrant notification to the relevant authority. The World Organization for Animal Health terrestrial animal health standards provide a framework for judging when animal health or welfare findings carry international reporting obligations, and the AVMA practice resources offer guidance on professional obligations in the United States. The threshold for reporting is legal and jurisdictional, not methodological, and the appraiser should flag the finding instead of decide the reporting question.

Frequently Asked Questions

How Much Time Should I Budget for Critical Appraisal of a Single Study?

A focused appraisal of one study typically requires 30 to 60 minutes once you are familiar with the chosen tool. First-time users should expect longer, particularly with tools that require domain-level judgment instead of simple yes or no responses. The review of critical appraisal tools by Crowe and Sheppard found that most tools lack published guidance for use, which increases the time needed to interpret ambiguous items. For systematic reviews, budget additional time because you must appraise both the review methods and the underlying studies. If you are appraising multiple studies for a review project, consider piloting the tool on two or three papers first to standardize your approach and reduce later rework.

What Should I Do When the Ideal Tool Is Not Available for My Study Design?

Use the closest validated tool and document the adaptation explicitly in your methods. For example, when a veterinary study uses a non-randomised intervention design, MINORS is a reasonable choice even though it was developed partly with surgical populations in mind. The systematic review of methodological assessment tools by Zeng and colleagues recommends MINORS for non-randomised interventional studies. If you modify items, state which items were changed and why, and consider whether the modification affects comparability with other appraisals. Avoid building a de novo tool unless no existing option fits, because most critical appraisal tools have not undergone rigorous validation or reliability testing, and an untested new tool compounds that problem.

How Does Critical Appraisal Differ for Livestock and Production Animal Research?

Production animal research frequently uses group-level interventions, cluster randomisation, and outcomes measured at herd or flock level. Standard tools designed for individually randomised clinical trials may not capture important sources of bias such as contamination between pens, partial blinding of outcome assessors, or unit-of-analysis errors. The Cochrane risk of bias tool remains the best available option for randomised trials, but you must adapt signaling questions to the cluster or group level. For observational herd-level studies, the Newcastle-Ottawa Scale can be used with attention to how exposure and outcome ascertainment apply to production records. Reporting standards such as REFLECT, available through the EQUATOR Network library, provide guidance on what should have been reported, which informs your appraisal of completeness.

What Records Should I Keep When Appraising Studies for a Review or Guideline?

Maintain a structured appraisal file containing the tool version, the completed checklist for each study, the identity and credentials of each appraiser, and the date of appraisal. Record disagreements between appraisers and how they were resolved, because inter-rater reliability varies substantially across tools and reviewer pairs. Keep a log of any tool modifications and the rationale for each change. If you are appraising for a systematic review, preserve the appraisal results in a format that links each judgment to the specific study section that supports it. This documentation supports reproducibility and allows a second reviewer to verify your decisions without repeating the full appraisal.

How Do I Explain Appraisal Findings to a Clinician or Supervisor Who Disagrees?

Focus on the specific methodological feature that drives your concern instead of the overall score. Name the domain, quote the relevant study methods, and explain how the flaw could distort the clinical conclusion. For example, if allocation concealment was not described, explain that treatment groups may differ in prognosis independent of the intervention. The Cochrane risk of bias tool is recommended for randomised trials precisely because it directs attention to mechanisms of bias instead of summary scores. Acknowledge that appraisal assesses risk, not certainty of harm, and that a flawed study may still provide useful information if its limitations are understood. Offer a sensitivity analysis or a cautious interpretation as a constructive path forward.

Can I Use One Appraisal Tool Across All Study Types in a Mixed-Methods Review?

Using a single tool across different study designs is possible but requires justification. Some tools are explicitly designed for multiple designs, yet most published tools lack documented development and validation, which makes cross-design comparisons difficult. For mixed-methods veterinary research, appraise each component with a design-appropriate tool and then synthesise the results using a narrative integration instead of a common score. The Joanna Briggs Institute tools have been used in this way for systematic reviews with heterogeneous study types, including policy and management interventions. Report the tool used for each study design separately so readers can judge whether the appraisal was fit for purpose.

Related Clinical & Scientific Guides

• Conducting Systematic Reviews of Veterinary Diagnostic Test Accuracy
• Bias in Veterinary Research: Types, Sources, and Mitigation
• Cluster Randomized Trials in Veterinary Research: Design and Analysis

References and Further Reading

• The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.. 2015.
• A review of critical appraisal tools show they lack rigor: Alternative tool structure is proposed.. 2011.
• Endothelial Dysfunction as a Key Link between Cardiovascular Disease and Frailty: A Systematic Review.. 2024.
• Impact of choice of quality appraisal tool for systematic reviews in overviews.. 2014.
• CAT HPPR: a critical appraisal tool to assess the quality of systematic, rapid, and scoping reviews investigating interventions in health promotion and prevention.. 2022.
• Implementation of policy and management interventions to improve health and care workforce capacity to address the COVID-19 pandemic response: a systematic review.. 2023.
• ARRIVE Guidelines 2.0 for Reporting Animal Research. PLOS Biology, 2020.
• EQUATOR Network Reporting Guidelines. EQUATOR Network.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Critical Appraisal of Randomized Controlled Trials in Veterinary Medicine
• Appraising Diagnostic Accuracy Studies in Veterinary Medicine
• Using Mixed Methods in Veterinary Research
• Conducting Qualitative Research in Veterinary Settings
• How to Write a Research Protocol for Veterinary Studies

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.